Edaravone 68083-0500-02
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 6, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA216199
Need to source Edaravone? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Edaravone | 30 mg/100mL |
Selected Package
68083-0500-02Selected2 POUCH in 1 CARTON (68083-500-02) / 1 BAG in 1 POUCH / 100 mL in 1 BAG